ESNATS conference on 16 September 2013 in Linz, Austria
The ESNATS - Embryonic Stem cell-based Novel Alternative Testing Strategies – Project aims to develop a novel toxicity test platform based on embryonic stem cells (ESCs), in particular human ESC (hESCs) to accelerate drug development, reduce related R&D costs and propose a powerful alternative to animal tests.
The ESNATS Project will hold its conference together with the EUSAAT congress - The European Society for Alternatives to Animal Testing on 16 September 2013 in Linz, Austria.
The aim of this conference is to:
- Disseminate the major achievements of the project, highlight the biomarker study and the test battery;
- Discuss the perspectives for future work: how to use the ESNATS results in further research and the future of stem cells in toxicity testing.
For more information about the programme, click here.
To register, please visit the EUSAAT congress website.
You can either attend the whole EUSAAT congress (Regular congress which includes the ESNATS conference) or only the ESNATS conference (Day ticket).
Last changed: 08/30/2013